{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T15:01:33Z","timestamp":1790262093957,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"vor","delay-in-days":83,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81803152"],"award-info":[{"award-number":["81803152"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-026-05513-z","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T20:14:11Z","timestamp":1783109651000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A machine-learning-derived multi-cell death mode signature predicts melanoma prognosis and reveals an immune-cold tumor microenvironment"],"prefix":"10.1007","volume":"17","author":[{"given":"Dan","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuze","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahong","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaheng","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,3]]},"reference":[{"issue":"5","key":"5513_CR1","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1111\/jdv.18701","volume":"37","author":"M Kostaki","year":"2023","unstructured":"Kostaki M, Plaka M, Moustaki M, et al. Cutaneous melanoma metastases: clinical and dermoscopic findings. J Eur Acad Dermatol Venereol. 2023;37(5):941\u20134. https:\/\/doi.org\/10.1111\/jdv.18701.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"5513_CR2","doi-asserted-by":"publisher","first-page":"e70051","DOI":"10.1111\/pcmr.70051","volume":"38","author":"J Nowowiejska","year":"2025","unstructured":"Nowowiejska J, Ordon AJ, Purpurowicz P, Argenziano G, Piccolo V. Many faces of melanoma: a comparison between cutaneous, mucosal, acral, nail, and ocular malignancy. Pigment Cell Melanoma Res. 2025;38(5):e70051. https:\/\/doi.org\/10.1111\/pcmr.70051.","journal-title":"Pigment Cell Melanoma Res"},{"issue":"1","key":"5513_CR3","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/exd.14489","volume":"31","author":"GL Parkman","year":"2022","unstructured":"Parkman GL, Foth M, Kircher DA, Holmen SL, McMahon M. The role of PI3\u2019-lipid signalling in melanoma initiation, progression and maintenance. Exp Dermatol. 2022;31(1):43\u201356. https:\/\/doi.org\/10.1111\/exd.14489.","journal-title":"Exp Dermatol"},{"issue":"7","key":"5513_CR4","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1111\/exd.13002","volume":"25","author":"SJ Hachey","year":"2016","unstructured":"Hachey SJ, Boiko AD. Therapeutic implications of melanoma heterogeneity. Exp Dermatol. 2016;25(7):497\u2013500. https:\/\/doi.org\/10.1111\/exd.13002.","journal-title":"Exp Dermatol"},{"issue":"10304","key":"5513_CR5","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/S0140-6736(21)01206-X","volume":"398","author":"MS Carlino","year":"2021","unstructured":"Carlino MS, Larkin J, Long GV. Immune checkpoint inhibitors in melanoma. Lancet. 2021;398(10304):1002\u201314. https:\/\/doi.org\/10.1016\/S0140-6736(21)01206-X.","journal-title":"Lancet"},{"issue":"3","key":"5513_CR6","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1111\/exd.14750","volume":"32","author":"Y Zou","year":"2023","unstructured":"Zou Y, Yaguchi T. Programmed cell death-1 blockade therapy in melanoma: resistance mechanisms and combination strategies. Exp Dermatol. 2023;32(3):264\u201375. https:\/\/doi.org\/10.1111\/exd.14750.","journal-title":"Exp Dermatol"},{"issue":"10","key":"5513_CR7","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1016\/j.jid.2025.03.018","volume":"145","author":"J Xie","year":"2025","unstructured":"Xie J, Ma C, Zhao S, et al. Deubiquitination by USP7 stabilizes JunD and activates AIFM2 (FSP1) to inhibit ferroptosis in melanoma. J Invest Dermatol. 2025;145(10):2562\u2013e25755. https:\/\/doi.org\/10.1016\/j.jid.2025.03.018.","journal-title":"J Invest Dermatol"},{"issue":"7823","key":"5513_CR8","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/s41586-020-2623-z","volume":"585","author":"JM Ubellacker","year":"2020","unstructured":"Ubellacker JM, Tasdogan A, Ramesh V, et al. Lymph protects metastasizing melanoma cells from ferroptosis. Nature. 2020;585(7823):113\u20138. https:\/\/doi.org\/10.1038\/s41586-020-2623-z.","journal-title":"Nature"},{"issue":"3","key":"5513_CR9","doi-asserted-by":"publisher","first-page":"e008554","DOI":"10.1136\/jitc-2023-008554","volume":"12","author":"Q Tao","year":"2024","unstructured":"Tao Q, Liu N, Wu J, Chen J, Chen X, Peng C. Mefloquine enhances the efficacy of anti-PD-1 immunotherapy via IFN-\u03b3-STAT1-IRF1-LPCAT3-induced ferroptosis in tumors. J Immunother Cancer. 2024;12(3):e008554. https:\/\/doi.org\/10.1136\/jitc-2023-008554. Published 2024 Mar 11.","journal-title":"J Immunother Cancer"},{"issue":"7969","key":"5513_CR10","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/s41586-023-06231-0","volume":"619","author":"L Bod","year":"2023","unstructured":"Bod L, Kye YC, Shi J, et al. B-cell-specific checkpoint molecules that regulate anti-tumour immunity. Nature. 2023;619(7969):348\u201356. https:\/\/doi.org\/10.1038\/s41586-023-06231-0.","journal-title":"Nature"},{"issue":"1","key":"5513_CR11","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1186\/s12967-025-06812-9","volume":"23","author":"J Xie","year":"2025","unstructured":"Xie J, Zhang P, Liu Y, et al. USP5-Mediated PD-L1 deubiquitination regulates immunotherapy efficacy in melanoma. J Transl Med. 2025;23(1):778. https:\/\/doi.org\/10.1186\/s12967-025-06812-9. Published 2025 Jul 10.","journal-title":"J Transl Med"},{"issue":"14","key":"5513_CR12","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1056\/NEJMra1814259","volume":"380","author":"A Rajkomar","year":"2019","unstructured":"Rajkomar A, Dean J, Kohane I. Machine learning in medicine. N Engl J Med. 2019;380(14):1347\u201358. https:\/\/doi.org\/10.1056\/NEJMra1814259.","journal-title":"N Engl J Med"},{"issue":"48","key":"5513_CR13","doi-asserted-by":"publisher","first-page":"20429","DOI":"10.1073\/pnas.0905139106","volume":"106","author":"D Bogunovic","year":"2009","unstructured":"Bogunovic D, O\u2019Neill DW, Belitskaya-Levy I, Vacic V, et al. Immune profile and mitotic index of metastatic melanoma lesions enhance clinical staging in predicting patient survival. Proc Natl Acad Sci U S A. 2009;106(48):20429\u201334.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"13","key":"5513_CR14","doi-asserted-by":"publisher","first-page":"3356","DOI":"10.1158\/1078-0432.CCR-09-2509","volume":"16","author":"G J\u00f6nsson","year":"2010","unstructured":"J\u00f6nsson G, Busch C, Knappskog S, Geisler J, et al. Gene expression profiling-based identification of molecular subtypes in stage IV melanomas with different clinical outcome. Clin Cancer Res. 2010;16(13):3356\u201367.","journal-title":"Clin Cancer Res"},{"issue":"7791","key":"5513_CR15","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/s41586-019-1914-8","volume":"577","author":"R Cabrita","year":"2020","unstructured":"Cabrita R, Lauss M, Sanna A, Donia M, et al. Tertiary lymphoid structures improve immunotherapy and survival in melanoma. Nature. 2020;577(7791):561\u20135.","journal-title":"Nature"},{"issue":"9","key":"5513_CR16","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.92102","volume":"2","author":"B Badal","year":"2017","unstructured":"Badal B, Solovyov A, Di Cecilia S, Chan JM et al. Transcriptional dissection of melanoma identifies a high-risk subtype underlying TP53 family genes and epigenome deregulation. JCI Insight 2017;2(9):e92102.","journal-title":"JCI Insight"},{"key":"5513_CR17","doi-asserted-by":"publisher","first-page":"106936","DOI":"10.1016\/j.ijsu.2022.106936","volume":"107","author":"Y Zou","year":"2022","unstructured":"Zou Y, Xie J, Zheng S, et al. Leveraging diverse cell-death patterns to predict the prognosis and drug sensitivity of triple-negative breast cancer patients after surgery. Int J Surg. 2022;107:106936. https:\/\/doi.org\/10.1016\/j.ijsu.2022.106936.","journal-title":"Int J Surg"},{"key":"5513_CR18","doi-asserted-by":"publisher","first-page":"116350","DOI":"10.1016\/j.scriptamat.2024.116350","volume":"255","author":"D Ren","year":"2025","unstructured":"Ren D, Wang C, Wei X, et al. Harmonizing physical and deep learning modeling: a computationally efficient and interpretable approach for property prediction. Scripta Mater. 2025;255:116350. https:\/\/doi.org\/10.1016\/j.scriptamat.2024.116350.","journal-title":"Scripta Mater"},{"issue":"2","key":"5513_CR19","first-page":"152","volume":"8","author":"M Mahendran Botlagunta","year":"2024","unstructured":"Mahendran Botlagunta M, Botlagunta MD, Venkata C, Kanakapudi ZK. Correlation-based comparative machine learning analysis for the classification of metastatic breast cancer using blood profile. Eurasian J Med Oncol. 2024;8(2):152\u201364.","journal-title":"Eurasian J Med Oncol"},{"key":"5513_CR20","doi-asserted-by":"publisher","first-page":"9436238","DOI":"10.1155\/2024\/9436238","volume":"2024","author":"PS Ramalingam","year":"2024","unstructured":"Ramalingam PS, Raj DB, Subramanian M, Arumugam S. ML-based screening of miRNA inhibitors and intervention of lncRNA\/miRNA\/mRNA axis in oncogenic KRAS-associated colorectal cancer. Adv Public Health. 2024; 2024: 9436238. https:\/\/doi.org\/10.1155\/2024\/9436238","journal-title":"Adv Public Health"},{"issue":"6","key":"5513_CR21","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1109\/TCBB.2020.2973148","volume":"18","author":"X Li","year":"2021","unstructured":"Li X, Xiang J, Wang J, Li J, Wu FX, Li M. FUNMarker: fusion network-based method to identify prognostic and heterogeneous breast cancer biomarkers. IEEE\/ACM Trans Comput Biol Bioinform. 2021;18(6):2483\u201391. https:\/\/doi.org\/10.1109\/TCBB.2020.2973148.","journal-title":"IEEE\/ACM Trans Comput Biol Bioinform"},{"key":"5513_CR22","doi-asserted-by":"publisher","first-page":"125261","DOI":"10.1016\/j.talanta.2023.125261","volume":"267","author":"JY Lu","year":"2024","unstructured":"Lu JY, Guo Z, Huang WT, et al. Peptide-graphene logic sensing system for dual-mode detection of exosomes, molecular information processing and protection. Talanta. 2024;267:125261. https:\/\/doi.org\/10.1016\/j.talanta.2023.125261.","journal-title":"Talanta"},{"key":"5513_CR23","doi-asserted-by":"publisher","DOI":"10.1021\/acs.analchem.3c04746","author":"Y Sheng","year":"2024","unstructured":"Sheng Y, Wang J, Liu S, Jiang Y. IMN4NPD: an integrated molecular networking workflow for natural product dereplication. Anal Chem. 2024. https:\/\/doi.org\/10.1021\/acs.analchem.3c04746.","journal-title":"Anal Chem"},{"issue":"5","key":"5513_CR24","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.clbc.2025.03.006","volume":"25","author":"MS Hussain","year":"2025","unstructured":"Hussain MS, Ramalingam PS, Chellasamy G, Yun K, Bisht AS, Gupta G. Harnessing artificial intelligence for precision diagnosis and treatment of triple negative breast cancer. Clin Breast Cancer. 2025;25(5):406\u201321. https:\/\/doi.org\/10.1016\/j.clbc.2025.03.006.","journal-title":"Clin Breast Cancer"},{"key":"5513_CR25","doi-asserted-by":"publisher","first-page":"106873","DOI":"10.1016\/j.compbiomed.2023.106873","volume":"159","author":"M Zhu","year":"2023","unstructured":"Zhu M, Li C, Lv K, et al. MLSpatial: a machine-learning method to reconstruct the spatial distribution of cells from scRNA-seq by extracting spatial features. Comput Biol Med. 2023;159:106873. https:\/\/doi.org\/10.1016\/j.compbiomed.2023.106873.","journal-title":"Comput Biol Med"},{"issue":"4","key":"5513_CR26","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1080\/15384101.2015.1120915","volume":"15","author":"PA Lochhead","year":"2016","unstructured":"Lochhead PA, Clark J, Wang LZ, et al. Tumor cells with KRAS or BRAF mutations or ERK5\/MAPK7 amplification are not addicted to ERK5 activity for cell proliferation. Cell Cycle. 2016;15(4):506\u201318. https:\/\/doi.org\/10.1080\/15384101.2015.1120915.","journal-title":"Cell Cycle"},{"issue":"2","key":"5513_CR27","doi-asserted-by":"publisher","first-page":"644","DOI":"10.21873\/invivo.13123","volume":"37","author":"C Cacina","year":"2023","unstructured":"Cacina C, Ulu E, Arikan S, Surmen ST, Yaylim I. The investigation of MAPK7 gene variations in colorectal cancer risk. Vivo. 2023;37(2):644\u20138. https:\/\/doi.org\/10.21873\/invivo.13123.","journal-title":"Vivo"},{"key":"5513_CR28","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1186\/s12885-015-1455-y","volume":"15","author":"PR Gavine","year":"2015","unstructured":"Gavine PR, Wang M, Yu D, et al. Identification and validation of dysregulated MAPK7 (ERK5) as a novel oncogenic target in squamous cell lung and esophageal carcinoma. BMC Cancer. 2015;15:454. https:\/\/doi.org\/10.1186\/s12885-015-1455-y. Published 2015 Jun 4.","journal-title":"BMC Cancer"},{"key":"5513_CR29","doi-asserted-by":"publisher","first-page":"e14489","DOI":"10.1111\/cns.14489","volume":"30","author":"W-W Duan","year":"2024","unstructured":"Duan W-W, Yang L-T, Liu J, et al. A TGF-\u03b2 signaling-related lncRNA signature for prediction of glioma prognosis, immune microenvironment, and immunotherapy response. CNS Neurosci Ther. 2024;30:e14489. https:\/\/doi.org\/10.1111\/cns.14489.","journal-title":"CNS Neurosci Ther"},{"issue":"1","key":"5513_CR30","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s13062-024-00518-6","volume":"19","author":"Z Liu","year":"2024","unstructured":"Liu Z, Sun L, Zhu W, et al. Disulfidptosis signature predicts immune microenvironment and prognosis of gastric cancer. Biol Direct. 2024;19(1):65. https:\/\/doi.org\/10.1186\/s13062-024-00518-6. Published 2024 Aug 15.","journal-title":"Biol Direct"},{"key":"5513_CR31","doi-asserted-by":"publisher","first-page":"1689103","DOI":"10.3389\/fimmu.2025.1689103","volume":"16","author":"Z Zhang","year":"2025","unstructured":"Zhang Z, Wang Y, Yin W, et al. Identification and validation of prognostic genes and prognostic models associated with cutaneous melanoma and integrative stress response. Front Immunol. 2025;16:1689103. https:\/\/doi.org\/10.3389\/fimmu.2025.1689103. Published 2025 Dec 2.","journal-title":"Front Immunol"},{"key":"5513_CR32","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.2147\/JIR.S502203","volume":"18","author":"Y Zhu","year":"2025","unstructured":"Zhu Y, Zhang Q, Wang Y, et al. Identification of necroptosis and immune infiltration in heart failure through bioinformatics analysis. J Inflamm Res. 2025;18:2465\u201381. https:\/\/doi.org\/10.2147\/JIR.S502203. Published 2025 Feb 19.","journal-title":"J Inflamm Res"},{"issue":"33","key":"5513_CR33","doi-asserted-by":"publisher","first-page":"5553","DOI":"10.1038\/s41388-020-1379-0","volume":"39","author":"D Green","year":"2020","unstructured":"Green D, Eyre H, Singh A, et al. Targeting the MAPK7\/MMP9 axis for metastasis in primary bone cancer. Oncogene. 2020;39(33):5553\u201369. https:\/\/doi.org\/10.1038\/s41388-020-1379-0.","journal-title":"Oncogene"},{"issue":"11","key":"5513_CR34","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1002\/mc.22420","volume":"55","author":"F Tesser-Gamba","year":"2016","unstructured":"Tesser-Gamba F, Lopes LJ, Petrilli AS, Toledo SR. MAPK7 gene controls proliferation, migration and cell invasion in osteosarcoma. Mol Carcinog. 2016;55(11):1700\u201313. https:\/\/doi.org\/10.1002\/mc.22420.","journal-title":"Mol Carcinog"},{"issue":"1","key":"5513_CR35","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/s13045-017-0528-6","volume":"10","author":"D Zhang","year":"2017","unstructured":"Zhang D, Li H, Jiang X et al. Role of AP-2\u03b1 and MAPK7 in the regulation of autocrine TGF-\u03b2\/miR-200b signals to maintain epithelial-mesenchymal transition in cholangiocarcinoma. J Hematol Oncol. 2017;10(1):170. https:\/\/doi.org\/10.1186\/s13045-017-0528-6. Published 2017 Oct 30.","journal-title":"J Hematol Oncol"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-05513-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05513-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05513-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T14:03:13Z","timestamp":1790258593000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-026-05513-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,3]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5513"],"URL":"https:\/\/doi.org\/10.1007\/s12672-026-05513-z","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,3]]},"assertion":[{"value":"24 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1372"}}